← Back to Patent Explorer
US5135752A Expired / Lapsed US ⏱️ 0.0 years remaining

Buccal dosage form

Assignee: Actavis Laboratories UT Inc
•
Filing: 1988-10-14
•
Granted: 1992-08-04
•
Expires: 2008-10-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A matrix for a buccal dosage form which melts in the oral cavity at body temperature but will not spontaneously deform at higher temperatures encountered in shipment and storage comprises: ______________________________________ Low MW Polyethylene glycol 75-90% (M.P. about 37° C.) Medium to high MW polyethylene glycol 0-4% Long chain saturated carboxylic acid 0-4% Polyethylene oxide 0.1-4% (MW 100,000-5,000,000) Colloidal silica 10-20%. ______________________________________

Inventors

  • 👤 Wallace C. Snipes

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 13:32
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/02; A61K9/0012; A61K9/0053; A61K9/006; A61K9/20; A61K9/2004; A61K9/2009; A61K9/2013; A61K9/2022; A61K9/2031

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 68 words
A matrix composition for a buccal dosage form comprising ______________________________________ Low MW Polyethylene glycol 70-90% by weight having a molecular weight of about 1000 (M.P. about 37° C.) Medium to high MW Polyethylene glycol 0-4% by weight having a molecular weight of about 3350 to about 8000 Long chain saturated carboxylic acid 0-4% by weight Polyethylene oxide 0.1-4% by weight (MW 100,000-5,000,000) Colloidal silica 10-20% by weight ______________________________________
Claim 2
Dependent Claim 68 words
A matrix composition for a buccal dosage form comprising ______________________________________ Low MW Polyethylene glycol 70-90% by weight having a molecular weight of about 1000 (M.P. about 37° C.) Medium to high MW Polyethylene glycol 0-4% by weight having a molecular weight of about 3350 to about 8000 Long chain saturated carboxylic acid 0-4% by weight Polyethylene oxide 0.1-4% by weight (MW 100,000-5,000,000) Colloidal silica 10-20% by weight ______________________________________
Claim 3
Dependent Claim 14 words
The composition of claim 1 wherein said low MW polyethylene glycol is PEG 1000.
Claim 4
Dependent Claim 16 words
The composition of claim 1 wherein said medium to high MW polyethylene glycol is PEG 8000.
Claim 5
Dependent Claim 21 words
The composition of claim 1 wherein said long chain saturated carboxylic acid has 12 to 18 carbon atoms in the chain.
Claim 6
Dependent Claim 14 words
The composition of claim 3 wherein said long chain carboxylic acid is myristic acid.
Claim 7
Dependent Claim 15 words
The composition of claim 1 wherein said polyethylene oxide has a MW of about 5,000,000.
Claim 8
Dependent Claim 22 words
The composition of claim 1 wherein said low molecular weight polyethylene glycol is present in a proportion of about 82.5% by weight.
Claim 9
Dependent Claim 15 words
The composition of claim 7 wherein said low molecular weight polyethylene glycol is PEG 1000.
Claim 10
Dependent Claim 23 words
The composition of claim 1 wherein said medium to high molecular weight PEG is present in a proportion of about 0.5% by weight.
Claim 11
Dependent Claim 16 words
The composition of claim 9 wherein said medium to high molecular weight PEG is PEG 8000.
Claim 12
Dependent Claim 22 words
The composition of claim 1 wherein said long chain saturated carboxylic acid is present in a proportion of about 0.5% by weight.
Claim 13
Dependent Claim 21 words
The composition of claim 11 wherein said long chain saturated carboxylic acid has 12 to 18 carbon atoms in the chain.
Claim 14
Dependent Claim 14 words
The composition of claim 12 wherein said long chain carboxylic acid is myristic acid.
Claim 15
Dependent Claim 19 words
The composition of claim 1 wherein said polyethylene oxide is present in a proportion of about 0.5% by weight.
Claim 16
Dependent Claim 16 words
The composition of claim 1 wherein said polyethylene oxide has a molecular weight of about 5,000,000.
Claim 17
Dependent Claim 22 words
The composition of claim 15 wherein said colloidal silica is present in a proportion of about 12% to about 18% by weight.
Claim 18
Dependent Claim 19 words
The composition of claim 16 wherein said colloidal silica is present in a proportion of about 16% by weight.
Claim 19
Dependent Claim 40 words
A matrix composition for a buccal dosage form comprising ______________________________________ Polyethylene glycol (MW 1000) 82.5% by weight Polyethylene glycol (MW 8,000) 0.5% by weight Myristic acid 0.5% by weight Polyethylene oxide 0.5% by weight Colloidal silica 16.0% by weight ______________________________________
Claim 20
Dependent Claim 40 words
A matrix composition for a buccal dosage form comprising ______________________________________ Polyethylene glycol (MW 1000) 82.5% by weight Polyethylene glycol (MW 8,000) 0.5% by weight Myristic acid 0.5% by weight Polyethylene oxide 0.5% by weight Colloidal silica 16.0% by weight ______________________________________

References Cited (Backward Citations)

US3932613A Cited
EP0001822A2 Cited
US4450877A Cited
DE3217071A1 Cited
US4629621A Cited
US4744976A Cited
US4774074A Cited
US4806337A Cited
EP0215635A2 Cited
US4764378A Cited
USRE33093E Cited
US4837025A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-08-04 1996-02-03 1996-08-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-08-04 2000-02-03 2000-08-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-08-04 2004-02-03 2004-08-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag